Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Can Quanta Double EPS by 2030 Without Losing Margin Discipline?
Can Quanta Double EPS by 2030 Without Losing Margin Discipline?

Quanta Services, Inc. PWR has built a reputation for delivering consistent growth while maintaining strong execution across complex infrastructure projects. With demand accelerating across grid

ATI and BWX Technologies Extend Strategic Partnership Through 2030
ATI and BWX Technologies Extend Strategic Partnership Through 2030

ATI Inc. ATI has announced a new long-term strategic material supply agreement with BWX Technologies, Inc. BWXT to reinforce a long-standing partnership that supports the U.S. Naval Nuclear

INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026

Indivior Pharmaceuticals INDV is benefiting from a market shift toward long-acting injectable care for opioid use disorder. Monthly treatment can improve adherence versus daily medications, which

Small-Cap Growth ETF (SLYG) Hits a New 52-Week High
Small-Cap Growth ETF (SLYG) Hits a New 52-Week High

For investors seeking momentum, State Street SPDR S&P 600 Small Cap Growth ETF SLYG is probably on the radar. The fund just hit a 52-week high and is up 31.48% from its 52-week low price of

Is Indivior Stock a Buy After Higher 2026 Guidance?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Is Indivior Stock a Buy After Higher 2026 Guidance?

Indivior Pharmaceuticals INDV has gained attention after a strong first-quarter showing and higher 2026 guidance. The company’s growth case still centers on Sublocade, its monthly extended-release

Best Momentum Stocks to Buy for June 12thPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Best Momentum Stocks to Buy for June 12th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 12:

ArcBest Corporation ARCB: This freight transportation services company has a Zacks

INDV Stock: What Sublocade Growth Signals for 2026Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
INDV Stock: What Sublocade Growth Signals for 2026

Indivior Pharmaceuticals INDV is leaning harder on one product to drive results. Sublocade, its monthly extended-release buprenorphine therapy, is now the main source of revenue growth and a key

Cognyte's Recurring Revenue Shift: Short-Term Strain Ahead?: https://staticx-tuner.zacks.com/images/default_article_images/default196.jpg
Cognyte's Recurring Revenue Shift: Short-Term Strain Ahead?

Cognyte Software Ltd.’s CGNT first quarter of fiscal 2027 results highlight a shift in its business model, with recurring revenues gaining significant traction. Recurring revenues were up 10% to

Implied Volatility Surging for Newmark Group Stock Options
Implied Volatility Surging for Newmark Group Stock Options

Investors in Newmark Group, Inc. NMRK need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $7.50 Call had some of the highest

Immunovant Stock Gains 12.4% in a Month: What's Driving It?
Immunovant Stock Gains 12.4% in a Month: What's Driving It?

Shares of Immunovant IMVT have risen 12.4% over the past month against the industry’s 1.5% decline, reflecting growing investor confidence in the company's long-term prospects. The rally has been

BABA Makes $1.5B Play for Pupu Amid Regulatory Scrutiny: What's Ahead?
BABA Makes $1.5B Play for Pupu Amid Regulatory Scrutiny: What's Ahead?

Alibaba Group BABA is offering $1.5 billion to acquire Chinese grocery delivery firm Pupu, initiating a bidding war as part of a broader campaign to wrest market share from online commerce rival

Will Rare Earth Expansion Drive UUUU's Next Growth Chapter?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Will Rare Earth Expansion Drive UUUU's Next Growth Chapter?

Energy Fuels Inc.s’ UUUU uranium operations have historically been the primary focus for investors, but its longer-term growth outlook is increasingly being shaped by its rare earth ambitions. The

Can Synopsys' Design IP Business Rebound in Fiscal 2026?
Can Synopsys' Design IP Business Rebound in Fiscal 2026?

Synopsys’ SNPS Design IP segment faced pressure in the second quarter of fiscal 2026. Revenues declined to $454.2 million from $482 million in the year-ago quarter, while adjusted operating margin

ETFs for Investors Seeking Balance Amid Ceasefire Optimism
ETFs for Investors Seeking Balance Amid Ceasefire Optimism

Ceasefire developments have played a key role in driving investor sentiment and short-term market direction. Markets have largely adopted a reactionary stance, responding swiftly to headlines

Here's Why Investors Should Bet on Expeditors Stock at Present
Here's Why Investors Should Bet on Expeditors Stock at Present

Shares of Expeditors International of Washington EXPD had a good run on the bourse over the past year. If you have not taken advantage of the share price appreciation yet, it’s time to do so.

Danaher Boosts Product Portfolio With the Acquisition of Masimo
Danaher Boosts Product Portfolio With the Acquisition of Masimo

Danaher Corporation DHR has completed the acquisition of Masimo Corp. for $180 per share in cash. The transaction was valued at approximately $9.9 billion in total, including assumed debt and net of

Can SMCI's Software Strategy Strengthen Data Center Deployments?Photo, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Can SMCI's Software Strategy Strengthen Data Center Deployments?

Super Micro Computer SMCI is on track to scale rack production capacity to more than 6,000 AI racks per month by the end of fiscal 2026, including 3,000 direct liquid cooling (DLC) racks monthly

4 High Earnings Yield Stocks to Add Value to Your Portfolio
4 High Earnings Yield Stocks to Add Value to Your Portfolio

Investors are navigating a market environment marked by persistent uncertainty. Geopolitical tensions in the Middle East, the lack of a lasting ceasefire, and concerns about the broader economic

Will Shipping Software Become Pitney Bowes' Next Growth Engine?Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Will Shipping Software Become Pitney Bowes' Next Growth Engine?

Pitney Bowes Inc. PBI appears to be positioning its shipping software business as a key growth driver. Recent management commentary suggests it could become the company’s next major growth engine

Keppel (KPELY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Keppel (KPELY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Shares of Keppel Corp. (KPELY) have been struggling lately and have lost 5.5% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Shares of GeoVax Labs Inc. (GOVX) have been struggling lately and have lost 34.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that

Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet
Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet

Promis Neurosciences (PMN) closed the last trading session at $10.7, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts See a 33.07% Upside in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST): Can the Stock Really Move This High?
Wall Street Analysts See a 33.07% Upside in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST): Can the Stock Really Move This High?

Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) closed the last trading session at $73.02, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if

Wall Street Analysts Believe Jones Lang LaSalle (JLL) Could Rally 33.61%: Here's is How to Trade
Wall Street Analysts Believe Jones Lang LaSalle (JLL) Could Rally 33.61%: Here's is How to Trade

Jones Lang LaSalle (JLL) closed the last trading session at $297.88, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Bears are Losing Control Over Smc (SMCAY), Here's Why It's a 'Buy' Now
Bears are Losing Control Over Smc (SMCAY), Here's Why It's a 'Buy' Now

The price trend for Smc Corporation (SMCAY) has been bearish lately and the stock has lost 5.8% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session